ROYALTY PHARMA PLC Performance
| 78081BAJ2 | 83.46 8.89 9.63% |
The bond holds a Beta of 0.58, which implies possible diversification benefits within a given portfolio. As returns on the market increase, ROYALTY's returns are expected to increase less than the market. However, during the bear market, the loss of holding ROYALTY is expected to be smaller as well.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days ROYALTY PHARMA PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for ROYALTY PHARMA PLC investors. ...more
| Yield To Maturity | 6.095 |
ROYALTY |
ROYALTY Relative Risk vs. Return Landscape
If you would invest 9,240 in ROYALTY PHARMA PLC on October 24, 2024 and sell it today you would lose (894.00) from holding ROYALTY PHARMA PLC or give up 9.68% of portfolio value over 90 days. ROYALTY PHARMA PLC is generating negative expected returns and assumes 1.2627% volatility on return distribution over the 90 days horizon. Simply put, 11% of bonds are less volatile than ROYALTY, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
ROYALTY Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ROYALTY's investment risk. Standard deviation is the most common way to measure market volatility of bonds, such as ROYALTY PHARMA PLC, and traders can use it to determine the average amount a ROYALTY's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1298
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 78081BAJ2 |
Estimated Market Risk
| 1.26 actual daily | 11 89% of assets are more volatile |
Expected Return
| -0.16 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ROYALTY is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ROYALTY by adding ROYALTY to a well-diversified portfolio.
About ROYALTY Performance
By analyzing ROYALTY's fundamental ratios, stakeholders can gain valuable insights into ROYALTY's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ROYALTY has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ROYALTY has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| ROYALTY PHARMA PLC generated a negative expected return over the last 90 days |
Other Information on Investing in ROYALTY Bond
ROYALTY financial ratios help investors to determine whether ROYALTY Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ROYALTY with respect to the benefits of owning ROYALTY security.